Oarsman Capital’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-500
Closed -$10.2K 397
2024
Q4
$10.2K Hold
500
﹤0.01% 692
2024
Q3
$14.6K Buy
+500
New +$14.6K ﹤0.01% 642